Dan Hartley
General Counsel bij GENUS PLC
Vermogen: 963 604 $ op 31-03-2024
Profiel
Dan Hartley is currently working as the Secretary & Group General Counsel at Genus Plc since 2014.
Prior to this, he worked as the Senior Vice President & International Counsel at Shire Plc.
Mr. Hartley completed his undergraduate degree from The University of Sydney and his graduate degree from the University of Wollongong.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GENUS PLC
0.07% | 14-09-2023 | 43 218 ( 0.07% ) | 963 604 $ | 31-03-2024 |
Actieve functies van Dan Hartley
| Bedrijven | Functie | Begin |
|---|---|---|
| GENUS PLC | General Counsel | 09-06-2014 |
Eerdere bekende functies van Dan Hartley
| Bedrijven | Functie | Einde |
|---|---|---|
| SHIRE | General Counsel | - |
Opleiding van Dan Hartley
| The University of Sydney | Undergraduate Degree |
| University of Wollongong | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GENUS PLC | Process Industries |
| Bedrijven in privébezit | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
